464 related articles for article (PubMed ID: 25539258)
61. The use of a vacuum-assisted biopsy device (Mammotome) in the early detection of breast cancer in the United Arab Emirates.
Faour I; Al-Salam S; El-Terifi H; El Taji H
Ann N Y Acad Sci; 2008 Sep; 1138():108-13. PubMed ID: 18837890
[TBL] [Abstract][Full Text] [Related]
62. [Mucocele-like lesion of the breast-histopathology and fine needle aspiration cytology changes].
Wong NL; Wan SK
Zhonghua Bing Li Xue Za Zhi; 1999 Oct; 28(5):327-30. PubMed ID: 11869541
[TBL] [Abstract][Full Text] [Related]
63. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract][Full Text] [Related]
64. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
[TBL] [Abstract][Full Text] [Related]
65. Outcome of high-risk lesions at MRI-guided 9-gauge vacuum- assisted breast biopsy.
Heller SL; Elias K; Gupta A; Greenwood HI; Mercado CL; Moy L
AJR Am J Roentgenol; 2014 Jan; 202(1):237-45. PubMed ID: 24370150
[TBL] [Abstract][Full Text] [Related]
66. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
67. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?
Liberman L; Tornos C; Huzjan R; Bartella L; Morris EA; Dershaw DD
AJR Am J Roentgenol; 2006 May; 186(5):1328-34. PubMed ID: 16632727
[TBL] [Abstract][Full Text] [Related]
68. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
[TBL] [Abstract][Full Text] [Related]
69. When is a diagnosis of sclerosing adenosis acceptable at core biopsy?
Gill HK; Ioffe OB; Berg WA
Radiology; 2003 Jul; 228(1):50-7. PubMed ID: 12738875
[TBL] [Abstract][Full Text] [Related]
70. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
71. Predictors of underestimation of malignancy after image-guided core needle biopsy diagnosis of flat epithelial atypia or atypical ductal hyperplasia.
Yu CC; Ueng SH; Cheung YC; Shen SC; Kuo WL; Tsai HP; Lo YF; Chen SC
Breast J; 2015; 21(3):224-32. PubMed ID: 25772033
[TBL] [Abstract][Full Text] [Related]
72. High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation.
Lourenco AP; Khalil H; Sanford M; Donegan L
AJR Am J Roentgenol; 2014 Sep; 203(3):682-6. PubMed ID: 25148176
[TBL] [Abstract][Full Text] [Related]
73. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
[TBL] [Abstract][Full Text] [Related]
74. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.
Jaffer S; Nagi C; Bleiweiss IJ
Cancer; 2009 Jul; 115(13):2837-43. PubMed ID: 19402174
[TBL] [Abstract][Full Text] [Related]
75. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy.
Liberman L; Cohen MA; Dershaw DD; Abramson AF; Hann LE; Rosen PP
AJR Am J Roentgenol; 1995 May; 164(5):1111-3. PubMed ID: 7717215
[TBL] [Abstract][Full Text] [Related]
76. Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital.
Margolin FR; Leung JW; Jacobs RP; Denny SR
AJR Am J Roentgenol; 2001 Sep; 177(3):559-64. PubMed ID: 11517047
[TBL] [Abstract][Full Text] [Related]
77. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
78. Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy.
Holley SO; Appleton CM; Farria DM; Reichert VC; Warrick J; Allred DC; Monsees BS
Radiology; 2012 Nov; 265(2):379-84. PubMed ID: 22952379
[TBL] [Abstract][Full Text] [Related]
79. All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excision.
Ouldamer L; Poisson E; Arbion F; Bonneau C; Vildé A; Body G; Michenet P
Breast; 2018 Aug; 40():4-9. PubMed ID: 29665448
[TBL] [Abstract][Full Text] [Related]
80. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
